Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer.

about

Locoregional therapy and systemic cetuximab to treat colorectal liver metastases.Advances and directions in chemotherapy using implantable port systems for colorectal cancer: a historical review.Prognostic significance of opioid use in the active treatment of advanced colorectal cancer.

P2860

Q35746556-9A34A8BF-6C3B-4949-BACC-55CFF28B514D Q38124755-EDE175CE-2741-45C9-BD79-2033E4D2196D Q38292435-3E83B8A3-5190-4132-804D-805DF4156AE5

P2860

Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer.

Item

http://www.wikidata.org/entity/Q35995438

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Optimal use of current chemoth ...... or advanced colorectal cancer.

@ast

Optimal use of current chemoth ...... or advanced colorectal cancer.

@en

type

Item

label

Optimal use of current chemoth ...... or advanced colorectal cancer.

@ast

Optimal use of current chemoth ...... or advanced colorectal cancer.

@en

prefLabel

Optimal use of current chemoth ...... or advanced colorectal cancer.

@ast

Optimal use of current chemoth ...... or advanced colorectal cancer.

@en

P1476

Optimal use of current chemoth ...... or advanced colorectal cancer.

@en

P2093

Junichiro Hiro

http://www.w3.org/2001/XMLSchema#string

Koji Tanaka

http://www.w3.org/2001/XMLSchema#string

Masato Kusunoki

http://www.w3.org/2001/XMLSchema#string

Yasuhiko Mohri

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Inoue

http://www.w3.org/2001/XMLSchema#string

Yuji Toiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

Current directions in chemotherapy for colorectal cancer.

A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.

P304

363-368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2011.508

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228083008

http://www.w3.org/2001/XMLSchema#string

P698

22740912

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

chemotherapy

P932

3362426

http://www.w3.org/2001/XMLSchema#string

Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer.

about

P2860

P2860

Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932